by telrheum | Sep 28, 2024 | Spondyloarthritis, Acute Phase Reactants, Ankylosing Spondylitis, C-reactive Protein, JAK Inhibitor, Tofacitinib
This article presents a post hoc analysis of how baseline (BL) C-Reactive Protein (CRP) levels affect the efficacy and safety of Tofacitinib, a medication used to treat Ankylosing Spondylitis (AS). Tofacitinib is a Janus kinase inhibitor, a type of drug that helps...
by telrheum | Sep 22, 2024 | Psoriasis, Acute Phase Reactants, C-reactive Protein, Psoriatic Arthritis
The study titled “Higher Levels of High-sensitivity CRP Are Associated with Future Risk of Developing Psoriatic Arthritis Among Patients with Psoriasis” investigates whether high levels of high-sensitivity C-Reactive Protein (hs-CRP), a marker of inflammation in the...
